Abstract
End-Stage Kidney Disease (ESKD) has a major effect on global health, both as a direct cause of global morbidity and mortality. Peritoneal Dialysis (PD) utilization increases gradually due to increase of patient's awareness for different types of RRT. Glucose constitutes the main component of the PD fluid utilized by the patients.
Highlights
The K/DOQI has defined the Chronic Kidney Disease (CKD) as kidney damage or Glomerular Filtration Rate (GFR) < 60 mL/min/1.73 m2 for 3 months or more, irrespective of cause
Percentage of patients with normal serum calcium improved from 58.7% to 85.2%
Percentage of patients with normal serum phosphate level reached 54.7% compared with 36.5% before Peritoneal Dialysis (PD) therapy, normal potassium level increased to 85.9% compared to 58.7% pre-PD, but patients had potassium value less than 3.5 mmol on PD increased to 12.5% from 3.2% pre-PD
Summary
The K/DOQI has defined the Chronic Kidney Disease (CKD) as kidney damage or Glomerular Filtration Rate (GFR) < 60 mL/min/1.73 m2 for 3 months or more, irrespective of cause. Kidney damage in many kidney diseases can be ascertained by the presence of albuminuria, defined as albumin-to-creatinine ratio > 30 mg/g in two of three spot urine specimens [1]. Kidney disease has a major effect on global health [2], both as a direct cause of global morbidity and mortality and as an important risk factor for Cardiovascular Disease (CVD) [3]. End-Stage Kidney Disease (ESKD) has a major effect on global health, both as a direct cause of global morbidity and mortality. Glucose constitutes the main component of the PD fluid utilized by the patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have